FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines
WEDNESDAY, Sept. 27, 2023 (HealthDay News) — Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label update for the drug made byContinue Reading